John C.M. Farquhar Sells 3,890 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 3,890 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The shares were sold at an average price of $50.00, for a total value of $194,500.00. Following the transaction, the chief executive officer owned 321,914 shares of the company’s stock, valued at approximately $16,095,700. This represents a 1.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The shares were sold at an average price of $46.42, for a total transaction of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.
• On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.31, for a total transaction of $638,730.22.
• On Friday, July 10th, John Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John Farquhar sold 38,900 shares of Heartflow stock. The shares were sold at an average price of $35.00, for a total value of $1,361,500.00.

Heartflow Stock Down 2.4%

HTFL opened at $48.33 on Wednesday. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $51.78. The stock has a market cap of $4.20 billion and a PE ratio of -26.41. The business has a 50 day moving average of $36.39 and a 200-day moving average of $31.21.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm’s revenue for the quarter was up 47.7% compared to the same quarter last year. Equities analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. JPMorgan Chase & Co. upped their price target on Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Stifel Nicolaus lifted their price objective on Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research note on Friday, August 14th. Wells Fargo & Company boosted their target price on Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Finally, Canaccord Genuity Group increased their target price on Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research note on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $44.88.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Engineers Gate Manager LP purchased a new stake in shares of Heartflow during the second quarter valued at approximately $590,000. Integrated Wealth Concepts LLC purchased a new position in Heartflow in the 2nd quarter worth approximately $53,000. Squarepoint Ops LLC lifted its position in Heartflow by 72.0% in the 2nd quarter. Squarepoint Ops LLC now owns 87,052 shares of the company’s stock valued at $2,554,000 after acquiring an additional 36,441 shares in the last quarter. Arizona State Retirement System purchased a new stake in Heartflow during the 2nd quarter valued at $312,000. Finally, Allianz Asset Management GmbH purchased a new stake in Heartflow during the 2nd quarter valued at $1,557,000.

Key Stories Impacting Heartflow

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
• Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
• Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
• Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
• Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
• Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).